MY198731A - Methods for treating ocular diseases - Google Patents
Methods for treating ocular diseasesInfo
- Publication number
- MY198731A MY198731A MYPI2019001713A MYPI2019001713A MY198731A MY 198731 A MY198731 A MY 198731A MY PI2019001713 A MYPI2019001713 A MY PI2019001713A MY PI2019001713 A MYPI2019001713 A MY PI2019001713A MY 198731 A MY198731 A MY 198731A
- Authority
- MY
- Malaysia
- Prior art keywords
- ocular disease
- group
- methods
- ocular diseases
- treating ocular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662401725P | 2016-09-29 | 2016-09-29 | |
| PCT/CN2017/104345 WO2018059543A1 (en) | 2016-09-29 | 2017-09-29 | Methods for treating ocular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY198731A true MY198731A (en) | 2023-09-20 |
Family
ID=61688114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2019001713A MY198731A (en) | 2016-09-29 | 2017-09-29 | Methods for treating ocular diseases |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11045435B2 (https=) |
| EP (1) | EP3518913B1 (https=) |
| JP (3) | JP2019531296A (https=) |
| KR (1) | KR102341446B1 (https=) |
| CN (1) | CN109789115A (https=) |
| CA (1) | CA3038845C (https=) |
| MY (1) | MY198731A (https=) |
| TW (1) | TWI765917B (https=) |
| WO (1) | WO2018059543A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110585196B (zh) * | 2018-06-13 | 2022-11-04 | 郭涛 | 一种治疗及预防眼科疾病的药物及其应用 |
| KR20240016352A (ko) * | 2021-05-28 | 2024-02-06 | 노벨와이즈 파마슈티칼 코포레이션 | 약물-내성 암을 치료하기 위한 조성물 및 방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006512318A (ja) * | 2002-11-12 | 2006-04-13 | アルコン，インコーポレイテッド | 眼の血管新生もしくは水腫状の疾患および障害を処置するためのヒストンデアセチラーゼインヒビター |
| US20050074497A1 (en) * | 2003-04-09 | 2005-04-07 | Schultz Clyde L. | Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases |
| JP4873904B2 (ja) * | 2005-08-22 | 2012-02-08 | 国立大学法人弘前大学 | 眼血管血流障害改善剤 |
| JP2008266322A (ja) | 2007-03-28 | 2008-11-06 | Santen Pharmaceut Co Ltd | ヒストン脱アセチル化酵素阻害作用を有する化合物を有効成分として含有する眼圧下降剤 |
| CA2630174A1 (en) * | 2007-05-02 | 2008-11-02 | Mitchell Alan Winnik | Loading quantum dots into thermo-responsive microgels by reversible transfer from organic solvents to water |
| EP2259771A1 (en) | 2008-03-03 | 2010-12-15 | Pharmalight Inc. | Stimulation of ocular retrobulbar flow using ocular irritants |
| RU2522444C2 (ru) * | 2008-08-27 | 2014-07-10 | Лео Фарма А/С | Производные пиридина в качестве ингибиторов рецепторов фактора роста эндотелия сосудов 2 подтипа (vegfr-2) и протеинтирозинкиназы |
| US7994357B2 (en) | 2009-04-03 | 2011-08-09 | Naturewise Biotech & Medicals Corporation | Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
| EP2236503B1 (en) * | 2009-04-03 | 2014-02-26 | NatureWise Biotech & Medicals Corporation | Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
| EP2277387B1 (en) * | 2009-07-22 | 2016-10-19 | NatureWise Biotech & Medicals Corporation | New use of histone deacetylase inhibitors in changing mrjp3 protein in royal jelly |
| KR102165421B1 (ko) * | 2011-05-09 | 2020-10-14 | 알레그로 파마슈티칼스, 인코포레이티드. | 인테그린 수용체 길항물질 및 이의 사용 방법 |
| US10370442B2 (en) | 2014-04-17 | 2019-08-06 | Teraclon Idf, S.L. | vNAR recombinant monoclonal antibodies that neutralize vascular endophelial growth factor VEGF |
| US9956254B2 (en) * | 2015-02-26 | 2018-05-01 | Naturewise Biotech & Medicals Corporation | Extract of taiwanese propolis for treating ocular diseases |
-
2017
- 2017-09-29 JP JP2019517058A patent/JP2019531296A/ja not_active Withdrawn
- 2017-09-29 US US15/720,785 patent/US11045435B2/en active Active
- 2017-09-29 WO PCT/CN2017/104345 patent/WO2018059543A1/en not_active Ceased
- 2017-09-29 MY MYPI2019001713A patent/MY198731A/en unknown
- 2017-09-29 TW TW106133818A patent/TWI765917B/zh active
- 2017-09-29 EP EP17854993.7A patent/EP3518913B1/en active Active
- 2017-09-29 CN CN201780056308.XA patent/CN109789115A/zh active Pending
- 2017-09-29 CA CA3038845A patent/CA3038845C/en active Active
- 2017-09-29 KR KR1020197009679A patent/KR102341446B1/ko active Active
-
2021
- 2021-05-12 JP JP2021081095A patent/JP2021138710A/ja active Pending
-
2023
- 2023-06-20 JP JP2023100597A patent/JP2023116748A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3518913A4 (en) | 2020-05-27 |
| WO2018059543A1 (en) | 2018-04-05 |
| JP2021138710A (ja) | 2021-09-16 |
| EP3518913A1 (en) | 2019-08-07 |
| JP2023116748A (ja) | 2023-08-22 |
| CN109789115A (zh) | 2019-05-21 |
| EP3518913C0 (en) | 2025-07-23 |
| US20180085329A1 (en) | 2018-03-29 |
| CA3038845A1 (en) | 2018-04-05 |
| KR20190045304A (ko) | 2019-05-02 |
| CA3038845C (en) | 2022-04-19 |
| KR102341446B1 (ko) | 2021-12-21 |
| US11045435B2 (en) | 2021-06-29 |
| JP2019531296A (ja) | 2019-10-31 |
| EP3518913B1 (en) | 2025-07-23 |
| TWI765917B (zh) | 2022-06-01 |
| TW201828933A (zh) | 2018-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014008759A2 (pt) | tratamento de doença ocular | |
| WO2016134223A3 (en) | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof | |
| MY176514A (en) | Compositions and methods for treating ocular edema, neovascularization and related diseases | |
| EP4360709A3 (en) | Use of a vegf antagonist to treat angiogenic eye disorders | |
| EA201492031A1 (ru) | Способы лечения диабетической ретинопатии и других офтальмологических заболеваний | |
| PH12015501942A1 (en) | Susbtituted 3-phenylpropylamine derivatives for the treatment of opthalmic diseases and disorders | |
| HK1258588A1 (zh) | 用於治疗眼科疾病的化合物和制剂 | |
| TN2019000136A1 (en) | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh | |
| EA201490721A1 (ru) | Лекарственное средство для лечения заболеваний передней камеры глаза, включающее ребамипид и агент, удерживающий слезы | |
| MX2020010968A (es) | Formulaciones de bevacizumab tamponadas para usarse en el tratamiento de enfermedades. | |
| MX2021008663A (es) | Anticuerpos mejorados contra il-6. | |
| SA521430084B1 (ar) | مركب حلقي غير متجانس، وتركيبة صيدلية تشتمل عليه، وطريقة لتحضيره واستخدامه | |
| JP2013523846A5 (https=) | ||
| MY198731A (en) | Methods for treating ocular diseases | |
| MX2019011242A (es) | Farmacos y composiciones para el tratamiento de trastornos oculares. | |
| EA201690903A1 (ru) | Лечение глаукомы с использованием лаквинимода | |
| MY199462A (en) | Methods and compositions for treating retina-associated disease using ccr3-inhibitors | |
| HK1198514A1 (en) | Substituted heterocyclic compounds for disease treatment | |
| MX2023012758A (es) | Composiciones y metodos para el tratamiento de la enfermedad ocular asociada con angiogenesis. | |
| PH12015501555A1 (en) | Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease | |
| WO2008124151A3 (en) | Use of creatine compounds for the treatment of eye disorders | |
| HK1219654A1 (zh) | 用於治疗眼科疾病和病症的方法 | |
| RU2010141560A (ru) | Лечение офтальмологических заболеваний | |
| HK1189820A (en) | Use of a vegf antagonist to treat angiogenic eye disorders | |
| TN2010000368A1 (en) | Treatment for ocular-related disorders |